01.01.2014 | Letter to the Editor
Induction of molecular remission by using anti-CC-chemokine receptor 4 (anti-CCR4) antibodies for adult T cell leukemia: a risk of opportunistic infection after treatment with anti-CCR4 antibodies
Erschienen in: Annals of Hematology | Ausgabe 1/2014
Einloggen, um Zugang zu erhalten